Evidence map›Paper›PMID 26667053›Full record

ArticleParasites & vectors2015

Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy.

Bo Huang, Changsheng Deng, Tao Yang, Linlu Xue, Qi Wang, Shiguang Huang, Xin-zhuan Su, Yajun Liu, Shaoqin Zheng, Yezhi Guan and 10 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Pathogens (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. The Diversity of theAntimicrobial agents and chemotherapy · 2019
    Article
  12. Article
  13. Article
  14. Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  15. Article
  16. Polymorphisms in the K13 Gene inThe American journal of tropical medicine and hygiene · 2018
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Bo HuangScience and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, PR China. huangbo198421@126.com.
Changsheng DengScience and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, PR China. dcs19811202@hotmail.com.
Tao YangScience and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, PR China. 942966792@qq.com.
Linlu XueScience and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, PR China. 1121595778@qq.com.
Qi WangScience and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, PR China. wangqi198169@163.com.
Shiguang HuangSchool of Medicine, Jinan University, Guangzhou, 510632, Guangdong, PR China. thshg@126.com.
Xin-zhuan SuLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. xsu@niaid.nih.gov.
Yajun LiuThe first affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, PR China. liuyajun9808@126.com.
Shaoqin ZhengScience and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, PR China. graceguangzhou@qq.com.
Yezhi GuanScience and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, PR China. gyz111@hotmail.com.
Qin XuResearch Institute of Tropical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, PR China. xuqin@163.com.
Jiuyao ZhouTraditional Chinese Medicine Collage, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, PR China. 68722514@qq.com.
Jie YuanTraditional Chinese Medicine Collage, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, PR China. 466754442@qq.com.
Afane BacarNational Malaria Control Programme, Moroni, Union of Comoros. anfanebacar@yahoo.fr.
Kamal Said AbdallahNational Malaria Control Programme, Moroni, Union of Comoros. kamalsaid2004@yahoo.fr.
Rachad AttoumaneNational Malaria Control Programme, Moroni, Union of Comoros. rachadkeke@yahoo.fr.
Ahamada M S A MlivaMinistry of Health Comoros, Moroni, Union of Comoros. amsamliva@yahoo.com.
Yanchun ZhongTraditional Chinese Medicine Collage, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, PR China. 447373997@qq.com.
Fangli LuDepartment of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, Guangdong, PR China. 489589715@qq.com.
Jianping SongScience and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, PR China. songjpgz@sina.com.
Guangzhou University of Chinese Medicine · CNFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CNJinan University · CNSun Yat-sen University · CNXiamen University · CN

Funding

Malaria Parasite Sexual Development, Drug Resistance, and EvolutionZIAAI000892 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SU, XINZHUAN · 2009 to 2025
$23.3M
Intramural NIH HHS
6 · The paper itself

Abstract

backgroundPlasmodium falciparum malaria is a significant public health problem in Comoros, and artemisinin combination therapy (ACT) remains the first choice for treating acute uncomplicated P. falciparum. The emergence and spread of artemisinin-resistant P. falciparum in Southeast Asia, associated with mutations in K13-propeller gene, poses a potential threat to ACT efficacy. Detection of mutations in the P. falciparum K13-propeller gene may provide the first-hand information on changes in parasite susceptibility to artemisinin. The objective of this study is to determinate the prevalence of mutant K13-propeller gene among the P. falciparum isolates collected from Grande Comore Island, Union of Comoros, where ACT has been in use since 2004.

methodsA total of 207 P. falciparum clinical isolates were collected from the island during March 2006 and October 2007 (n = 118) and March 2013 and December 2014 (n = 89). All isolates were analysed for single nucleotide polymorphisms (SNPs) and haplotypes in the K13-propeller gene using nested PCR and DNA sequencing.

resultsOnly three 2006-2007 samples carried SNPs in the K13-propeller gene, one having a synonymous (G538G) and the other having two non-synonymous (S477Y and D584E) substitutions leading to two mutated haplotypes (2.2%, 2/95). Three synonymous mutations (R471R, Y500Y, and G538G) (5.9%, 5/85) and 7 non-synonymous substitutions (21.2%, 18/85) with nine mutated haplotypes (18.8%, 16/85) were found in isolates from 2013 to 2014. However, none of the polymorphisms associated with artemisinin-resistance in Southeast Asia was detected from any of the parasites examined.

conclusionThis study showed increased K13-propeller gene diversity among P. falciparum populations on the Island over the course of 8 years (2006-2014). Nevertheless, none of the polymorphisms known to be associated with artemisinin resistance in Asia was detected in the parasite populations examined. Our data suggest that P. falciparum populations in Grande Comore are still effectively susceptible to artemisinin. Our results provide insights into P. falciparum populations regarding mutations in the gene associated with artemisinin resistance and will be useful for developing and updating anti-malarial guidance in Comoros.

Indexed as

Drug ResistanceGenetic MarkersAntimalarialsArtemisininsComorosGene FrequencyHaplotypesHumansMalaria, FalciparumPlasmodium falciparumPolymerase Chain ReactionPolymorphism, Single NucleotideSequence Analysis, DNAAntimalarialsartemisininArtemisininsGenetic Markers

Identifiers

PMID26667053
PMCPMC4678476
OpenAlexW2204448248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.